TACR1 and cancer: Accordingly, the administration of aprepitant prior to performing a biopsy (375–750 mg) or prior to and after (375–750 mg in both cases) oncological surgery procedures could decrease inflammation and cancer recurrence and metastasis (including brain metastasis) by the blockade of the NK-1R.